Hospital Purpan

Toulouse 31059

1 studies enrolling now · 3 studies all time

What they study most

Alpha1-Antitrypsin Deficiency, Cutaneous T-Cell Lymphoma, Multiple Myeloma, Non-Hodgkin's Lymphoma, Peripheral T-Cell Lymphoma

Studies at this site

• Study to Check the Safety of Fazirsiran and Learn if Fazirsiran Can Help People With Liver Disease and Scarring (Fibrosis) Due to an Abnormal Version of Alpha-1 Antitrypsin Protein — Recruiting now
• Phase 3 Study of Carfilzomib, Melphalan, Prednisone vs Bortezomib, Melphalan, Prednisone in Newly Diagnosed Multiple Myeloma — Completed
• A Phase II Clinical Trial of PXD101 in Patients With Recurrent or Refractory Cutaneous and Peripheral T-Cell Lymphomas — Stopped early